Feng Zhu
- Molecular Biology top 2%
- Oncology top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Immunology top 10%
- Co-authors
- Ann M. BodeZigang DongYong‐Yeon ChoWeiya MaTatyana A. ZykovaCong PengChengrong LuFaqing Tang
- Topics
- Cancer-related Molecular Pathways (18 papers)Cell death mechanisms and regulation (16 papers)FOXO transcription factor regulation (14 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Feng Zhu
118 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 2.6k
- Oncology 781
- Cancer Research 639
- Pathology and Forensic Medicine 445
- Immunology 372
Countries citing papers authored by Feng Zhu
This map shows the geographic impact of Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhu more than expected).
Fields of papers citing papers by Feng Zhu
This network shows the impact of papers produced by Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhu. The network helps show where Feng Zhu may publish in the future.
Co-authorship network of co-authors of Feng Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Feng Zhu. A scholar is included among the top collaborators of Feng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Zhu. Feng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 12 | |
| 5 | 25 | |
| 6 | 2 | |
| 7 | 21 | |
| 8 | 15 | |
| 9 | 47 | |
| 10 | 91 | |
| 11 | 4 | |
| 12 | 26 | |
| 13 | 33 | |
| 14 | 25 | |
| 15 | 45 | |
| 16 | 69 | |
| 17 | 74 | |
| 18 | 54 | |
| 19 | TOPK phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells | 1 |
| 20 | 34 |
About Feng Zhu
Feng Zhu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 122 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Cell death mechanisms and regulation (16 papers) and FOXO transcription factor regulation (14 papers). The work is most often cited by research in Cancer Research (639 citations), Applied Microbiology and Biotechnology (77 citations) and Molecular Biology (2.6k citations). Feng Zhu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Ann M. Bode, Zigang Dong, Yong‐Yeon Cho, Weiya Ma, Tatyana A. Zykova, Cong Peng, Chengrong Lu, Faqing Tang, Ke Yao and Duo Zheng. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.